UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Development of optimized vectors for gene therapy

Proceedings of the National Academy of Sciences - PNAS, 1999-01, Vol.96 (2), p.324-326

Nabel, G J

1999

Volltextzugriff (PDF)

NMR spectroscopy of HIV-1 gp120 outer domain

Retrovirology, 2012-09, Vol.9 (S2), p.P20-P20, Article P20

2012

Volltextzugriff (PDF)

Transforming epitope-specific gp120 monomer-based probes into immunogens with N-linked glycan masking

Retrovirology, 2012-09, Vol.9 (S2), p.P318-P318, Article P318

2012

Volltextzugriff (PDF)

A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults

Vaccine, 2010-12, Vol.29 (2), p.304-313

2010

Volltextzugriff (PDF)

Structure-guided modification and optimization of antibody VRC07

Retrovirology, 2012-09, Vol.9 (S2), p.O34-O34, Article O34

2012

Volltextzugriff (PDF)

Characteristics of HIV-1 gp120 molecules that bind ancestor, intermediate and mature forms of VRC01-like antibodies

Retrovirology, 2012-09, Vol.9 (S2), p.P68-P68, Article P68

2012

Volltextzugriff (PDF)

Partial germline reversions can increase VRC07 potency and breadth

Retrovirology, 2012-09, Vol.9 (S2), p.P101-P101, Article P101

2012

Volltextzugriff (PDF)

Hyperglycosylated resurfaced stabilized GP120 core as an immunogen elicits antibodies targeted at the CD4-binding site

Retrovirology, 2012-09, Vol.9 (S2), p.P23-P23, Article P23

2012

Volltextzugriff (PDF)

pH-Dependent Entry of Severe Acute Respiratory Syndrome Coronavirus Is Mediated by the Spike Glycoprotein and Enhanced by Dendritic Cell Transfer through DC-SIGN

Journal of Virology, 2004-06, Vol.78 (11), p.5642-5650

2004

Volltextzugriff (PDF)

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

Nature, 2004-04, Vol.428 (6982), p.561-564

2004

Volltextzugriff (PDF)

Deep sequencing with longitudinal sampling of a VRC01-like-antibody response in a chronically infected individual

Retrovirology, 2012-09, Vol.9 (S2), p.O36-O36, Article O36

2012

Volltextzugriff (PDF)

Challenges and opportunities for development of an AIDS vaccine

Nature (London), 2001-04, Vol.410 (6831), p.1002-1007

Nabel, Gary J

2001

Volltextzugriff (PDF)

Rational Design of AIDS Vaccines

Retrovirology, 2005-12, Vol.2 (S1), p.S28-S28, Article S28

Nabel, GJ

2005

Volltextzugriff (PDF)

P13-07 LB. A human blocking antibody to CCR5 partially protects against lentiviral infection in non-human primates

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.P402-P402, Article P402

2009

Volltextzugriff (PDF)

HIV vaccine design and the neutralizing antibody problem

Nature immunology, 2004-03, Vol.5 (3), p.233-236

2004

Volltextzugriff (PDF)

P04-38. Crystal structure of gp120 in complex with the CD4-binding-site antibody b13 suggests precise targeting is needed for neutralization

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.P66-P66, Article P66

2009

Volltextzugriff (PDF)

Heme oxygenase-1 protects against vascular constriction and proliferation

Nature medicine, 2001-06, Vol.7 (6), p.693-698

2001

Volltextzugriff (PDF)

Design of an HIV Env antigen that binds with high affinity to antibodies against linear, conformational and broadly neutralizing epitopes within V1/V2

Retrovirology, 2012-09, Vol.9 (S2), p.O31-O31, Article O31

2012

Volltextzugriff (PDF)

Viral immunity: Basic mechanisms and therapeutic applications—a Keystone Symposia report

Annals of the New York Academy of Sciences, 2023-03, Vol.1521 (1), p.32-45

2023

Volltextzugriff (PDF)

Adenovirus vector-based vaccines for human immunodeficiency virus type 1

Human gene therapy, 2005-02, Vol.16 (2), p.149-156

2005

Volltextzugriff (PDF)

P20-21 LB. Gene-to-gene differences in evolutionary rate between HIV-1 and natural SIV from sooty mangabeys: implications for vaccine tests in non-human primates

Retrovirology, 2009-10, Vol.6 (Suppl 3), p.P425-P425, Article P425

2009

Volltextzugriff (PDF)

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

Nature, 2003-08, Vol.424 (6949), p.681-684

2003

Volltextzugriff (PDF)

Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury

Nature medicine, 2000-08, Vol.6 (8), p.886-889

2000

Volltextzugriff (PDF)

Preserved CD4+ Central Memory T Cells and Survival in Vaccinated SIV-Challenged Monkeys

Science (American Association for the Advancement of Science), 2006-06, Vol.312 (5779), p.1530-1533

2006

Volltextzugriff (PDF)

Development of a preventive vaccine for Ebola virus infection in primates

Nature (London), 2000-11, Vol.408 (6812), p.605-609

2000

Volltextzugriff (PDF)

1 – 25 von 223

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(217)
Mit Volltextzugriff
(208)

Publikationsform

Artikel
(223)

Sprache

Englisch
(222)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(199)
Life Sciences & Biomedicine
(158)
Humans
(139)
Animals
(108)
Biological And Medical Sciences
(75)
Virology
(62)
Fundamental And Applied Biological Sciences. Psychology
(61)
Mice
(52)
Biochemistry & Molecular Biology
(50)
Aids/hiv
(48)
Medicine, Research & Experimental
(46)
Research & Experimental Medicine
(46)
Multidisciplinary Sciences
(43)
Science & Technology - Other Topics
(43)
Genetic Vectors
(41)
Molecular Sequence Data
(41)
Microbiology
(40)
Base Sequence
(38)
Transfection
(38)
Cell Biology
(36)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Development of optimized vectors for gene therapy

NMR spectroscopy of HIV-1 gp120 outer domain

Transforming epitope-specific gp120 monomer-based probes into immunogens with N-linked glycan masking

A replication defective recombinant Ad5 vaccine expressing Ebola virus GP is safe and immunogenic in healthy adults

Structure-guided modification and optimization of antibody VRC07

Characteristics of HIV-1 gp120 molecules that bind ancestor, intermediate and mature forms of VRC01-like antibodies

Partial germline reversions can increase VRC07 potency and breadth

Hyperglycosylated resurfaced stabilized GP120 core as an immunogen elicits antibodies targeted at the CD4-binding site

pH-Dependent Entry of Severe Acute Respiratory Syndrome Coronavirus Is Mediated by the Spike Glycoprotein and Enhanced by Dendritic Cell Transfer through DC-SIGN

A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice

Deep sequencing with longitudinal sampling of a VRC01-like-antibody response in a chronically infected individual

Challenges and opportunities for development of an AIDS vaccine

Rational Design of AIDS Vaccines

P13-07 LB. A human blocking antibody to CCR5 partially protects against lentiviral infection in non-human primates

HIV vaccine design and the neutralizing antibody problem

P04-38. Crystal structure of gp120 in complex with the CD4-binding-site antibody b13 suggests precise targeting is needed for neutralization

Heme oxygenase-1 protects against vascular constriction and proliferation

Design of an HIV Env antigen that binds with high affinity to antibodies against linear, conformational and broadly neutralizing epitopes within V1/V2

Viral immunity: Basic mechanisms and therapeutic applications—a Keystone Symposia report

Adenovirus vector-based vaccines for human immunodeficiency virus type 1

P20-21 LB. Gene-to-gene differences in evolutionary rate between HIV-1 and natural SIV from sooty mangabeys: implications for vaccine tests in non-human primates

Accelerated vaccination for Ebola virus haemorrhagic fever in non-human primates

Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury

Preserved CD4+ Central Memory T Cells and Survival in Vaccinated SIV-Challenged Monkeys

Development of a preventive vaccine for Ebola virus infection in primates

Suchergebnisse filtern